Corticosteroid plus β2-agonist in a single inhaler as reliever therapy in intermittent and mild asthma: a proof-of-concept systematic review and meta-analysis.
about
Corticosteroid plus β2-agonist in a single inhaler as reliever therapy in intermittent and mild asthma: a proof-of-concept systematic review and meta-analysis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Corticosteroid plus β2-agonist ...... atic review and meta-analysis.
@en
Corticosteroid plus β2-agonist ...... atic review and meta-analysis.
@nl
type
label
Corticosteroid plus β2-agonist ...... atic review and meta-analysis.
@en
Corticosteroid plus β2-agonist ...... atic review and meta-analysis.
@nl
prefLabel
Corticosteroid plus β2-agonist ...... atic review and meta-analysis.
@en
Corticosteroid plus β2-agonist ...... atic review and meta-analysis.
@nl
P2093
P2860
P921
P1433
P1476
Corticosteroid plus β2-agonist ...... atic review and meta-analysis.
@en
P2093
De Ying Kang
Hong Ping Zhang
P2860
P2888
P356
10.1186/S12931-017-0687-6
P5008
P577
2017-12-06T00:00:00Z
P6179
1099699548